SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-23-001034
Filing Date
2023-07-31
Accepted
2023-07-31 20:06:23
Documents
1
Period of Report
2023-07-26

Document Format Files

Seq Description Document Type Size
1 e618814_4-ttnp.html 4  
1 e618814_4-ttnp.xml 4 8754
  Complete submission text file 0001193805-23-001034.txt   10114
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 710 CARLYLE ST WOODMERE NY 11598
Business Address
Greenberg Eric Howard (Reporting) CIK: 0001943832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 231129151